Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2003
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003CA2428649A1 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/09/2003CA2406687A1 Chimeric promoters for controlling expression in muscle cells
05/08/2003WO2003038128A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038112A2 A composition and method to alter lean body mass and bone properties in a subject
05/08/2003WO2003038103A1 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003038034A2 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary
05/08/2003WO2003037920A2 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
05/08/2003WO2003037909A1 Acyclic linker-containing oligonucleotides and uses thereof
05/08/2003WO2003037370A2 Anthrax antigenic compositions
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037261A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003037166A2 Devices and methods for the restoration of a spinal disc
05/08/2003WO2003037165A2 System and method for the pretreatment of the endplates of an intervertebral disc
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003025187A3 Improvement of gene expression in vectors
05/08/2003WO2003022228A9 Method for producing transgenic birds and fish
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003006067A3 Composition comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis
05/08/2003WO2002098286A3 Implantation of biological pacemaker that is molecularly determined
05/08/2003WO2002092624A3 G-protein coupled receptor
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002086132A3 Viral vector system to transduce or infect a target adipose tissue site
05/08/2003WO2002076427A3 Ph sensitive liposomal drug delivery
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003US20030088087 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
05/08/2003US20030088082 Nucleotide sequences coding polypeptide for use in veterinary medicine
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087871 Antisense modulation of caspase 9 expression
05/08/2003US20030087868 Administration of a vector to cells in vivo comprising and expressing a transgene encoding beta-glucosidase, the vector is taken up by the cells, the transgene is expressed therein and and beta-glucosidase is produced
05/08/2003US20030087867 Administering to isolated tissue, a nucleic acid sequence delivery vehicle encoding nitric oxide synthase activity
05/08/2003US20030087866 Suppression of malignancy utilizing ribonucleotide reductase R1
05/08/2003US20030087863 Activation matrix metalloprotease; diagnosis of disease sensitivity; rheumatic diseases, bone disorders
05/08/2003US20030087862 Cancer control
05/08/2003US20030087861 Administering mixture of antibody and drug; cancer sensitivity
05/08/2003US20030087859 Therapy for vision defects, central nervous system disorders; retinal pigment epithelium; genetic engineering
05/08/2003US20030087858 Diagnostic and therapeutic compositions for alzheimer's disease
05/08/2003US20030087857 Antisense modulation of insulin-like growth factor binding protein 5 expression
05/08/2003US20030087856 Antisense modulation of IL-1 receptor-associated kinase-4 expression
05/08/2003US20030087852 Cancer gene therapy based on translational control of a suicide gene
05/08/2003US20030087850 Gene therapy for dry eye syndrome
05/08/2003US20030087846 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087810 Controlling gene expression in cells; anticancer agents; drug delivery
05/08/2003US20030087438 E1-revertant-free adenoviral composition
05/08/2003US20030087437 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells
05/08/2003US20030087436 Process for the production of biologically active polymeric nanoparticle-nucleic acid conjugates
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087432 Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture, methods for assaying the effect of substances on lineage-specific cell production, and cell compositions produced by these cultures
05/08/2003US20030087417 Newcastle disease virus infectious clones, vaccines and diagnostic assays
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087394 Nucleotides equences coding polypeptide for use in the treatment of pancreatic disorders
05/08/2003US20030087393 Endostatin for use in the treatment of cancer and tumor metastasis
05/08/2003US20030087378 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087377 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087341 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
05/08/2003US20030087317 Human NIM1 kinase
05/08/2003US20030087295 Methods and compositions for the treatment and diagnosis of pain disorders using 9805
05/08/2003US20030087266 IGs as modifiers of the p53 pathway and methods of use
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/08/2003US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
05/08/2003US20030087243 Diagnosis, prognosis and treatment of cancer related to the Barx2 gene
05/08/2003US20030087230 L-Ribo-LNA analogues
05/08/2003US20030086938 Effecting presentation to the animal's immune system of an immunogenically effective amount of at least one analogue of autologous beta amyloid (A beta ) protein or autologous amyloid precursor
05/08/2003US20030086933 Therapeutic systems
05/08/2003US20030086927 Administering to a host an agent which inhibits cyclin G1 protein, agent being administered in amount effective to inhibit cyclin G1 protein in tumor cells of host
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086915 Embryonic stem cells, clinical applications and methods for expanding in vitro
05/08/2003US20030086914 Method and device for inducing biological processes by micro-organs
05/08/2003US20030086913 For therapy of tumors and cancer
05/08/2003US20030086907 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
05/08/2003US20030086906 Method of inducing an immune response using vaccinia virus recombinants
05/08/2003US20030086904 Therapeutic regimen for treating cancer
05/08/2003US20030086903 Therapeutic regimen for treating cancer
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003CA2465402A1 Anthrax antigenic compositions
05/08/2003CA2465371A1 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
05/08/2003CA2465129A1 Acyclic linker-containing oligonucleotides and uses thereof
05/08/2003CA2465037A1 Genetic vaccine against human immunodeficiency virus
05/08/2003CA2464887A1 Methods and compositions for treating parkinson's disease
05/08/2003CA2464199A1 A composition and method to alter lean body mass and bone properties in a subject
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2361462A1 Induction of tolerance to a therapeutic polypeptide
05/07/2003EP1308517A1 Vectors for expressing multiple transgenes
05/07/2003EP1308516A1 Site-directed recombinase fusion proteins and corresponding polynucleotides, vectors and kits, and their uses for site-directed DNA recombination
05/07/2003EP1308513A1 Use of polypeptide
1 ... 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 ... 870